Pharmacology and Therapeutics
Showing page 3 of 8 pages of list content
-
Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence
This article's authors -
A Review of Dosages of Chloroquine and Hydroxychloroquine for COVID-19 in registered Clinical Trials during First Quarter of 2020
This article's authors -
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
This article's authors -
Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kongâs Omicron BA.2 wave: an observational study
This article's authors -
Hyperbaric Oxygen for Treatment of Long COVID Syndrome (HOT-LoCO); Protocol for a Randomised, Placebo-Controlled, Double-Blind, Phase II Clinical Trial
This article's authors -
Cannabis potential effects to prevent or attenuate SARS-COV2 contagion
This article's authors -
EARLY OUTPATIENT TREATMENT OF COVID-19: A RETROSPECTIVE ANALYSIS OF 392 CASES IN ITALY
This article's authors -
Pharmacokinetics of favipiravir in adults with mild COVID-19 in Thailand
This article's authors -
Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19
This article's authors -
PBPK-led guidance for cystic fibrosis patients taking elexacaftor-tezacaftor-ivacaftor with nirmatrelvir-ritonavir for the treatment of COVID-19
This article's authors